Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: ITP Registry and Accompanying Biospecimen Collection
Clinical trial update detailing an Immune thrombocytopenia registry and accompanying biospecimen collection led by Jena University Hospital.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP
An observational, multicenter study evaluating how Doptelet (eltrombopag) is used and its effectiveness in patients with immune thrombocytop…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial is evaluating an anti-CD38 antibody in elderly patients with immune thrombocytopenia. The study is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP [Phase 2]
This is a Phase 2 clinical trial comparing iguratimod plus low-dose rituximab to low-dose rituximab alone in corticosteroid-resistant or rel…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic throm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP [Phase 4]
Phase 4 trial evaluating how often patients experience a prolonged response after stopping thrombopoietin-receptor agonists in persistent im…
-
CLINICAL_TRIALS other · 2025-07-01Clinical Trial Update: Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia
A clinical trial update evaluating serum lactate dehydrogenase levels in immune thrombocytopenia with status not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia [Phase 3]
Phase 3 clinical trial comparing romiplostim plus dexamethasone versus dexamethasone alone in newly diagnosed primary immune thrombocytopeni…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: "Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
A clinical trial is investigating CTLA-4 gene single-nucleotide polymorphisms in children with primary immune thrombocytopenia. The trial st…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia [Phase 2]
TAK-079 was studied in adults with persistent or chronic primary immune thrombocytopenia in a Phase 2 trial. The study is completed and resu…
-
CLINICAL_TRIALS other · 2025-06-13Clinical Trial Update: A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY [Phase 2]
A Phase 2 clinical trial evaluating the safety and clinical activity of belantamab mafodotin in adults with primary immune thrombocytopenia …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia [Phase 1, Phase 2]
A Phase 1/2 dose-escalation and dose-optimization study to evaluate the safety and efficacy of CID-103 in adults with chronic immune thrombo…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing the safety and efficacy of daratumumab for primary immune thrombocytopenia is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial [Phase 2]
Phase 2 multicenter interventional trial evaluating romiplostim combined with glucocorticoids as first-line therapy for newly diagnosed adul…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 clinical trial evaluating TQB3473 tablets versus placebo in adults with Primary Immune Thrombocytopenia is currently recruiting.
-
EMA approval · 2025-05-16EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG
EMA authorised Deqsiga, a human normal immunoglobulin product from Takeda Manufacturing Austria AG, for several immunologic and neuropathic …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia [Phase 1, Phase 2]
A Phase 1/2 study of ESG206 in patients with primary immune thrombocytopenia is currently recruiting. The trial aims to evaluate safety and …
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical study evaluating YTS109 cells in relapsed/refractory systemic lupus erythematosus, including lupus nephritis and immune t…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia [EARLY_Phase 1]
This clinical trial is an early-phase study evaluating CD19 CAR NK cells for treating refractory primary immune thrombocytopenia (alloimmune…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP
This real-world study evaluated the activity and safety of fostamatinib in consecutive adults with immune thrombocytopenia, including chroni…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
This completed clinical trial update reports on the response rate and duration of response after stopping thrombopoietin receptor agonists i…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts [Phase 4]
A Phase 4 randomized trial comparing optimized recombinant human thrombopoietin (rhTPO) versus eltrombopag in patients with previously treat…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study of CM313 given as a subcutaneous injection for primary immune thrombocytopenia is currently active but not recruiting. The tri…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
A Spanish registry (RESTI) for Primary Immune Thrombocytopenia and other immune thrombocytopenias is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP [Phase 2, Phase 3]
Clinical trial evaluating different cycles of high-dose dexamethasone in immune thrombocytopenia (ITP); currently not recruiting.